<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7F63F731-9323-45F0-AEC5-00FEDAE4B1CB"><gtr:id>7F63F731-9323-45F0-AEC5-00FEDAE4B1CB</gtr:id><gtr:name>Children's National Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7E833A22-66FB-41DB-BB4E-283D08AF9A6E"><gtr:id>7E833A22-66FB-41DB-BB4E-283D08AF9A6E</gtr:id><gtr:name>Janssen Research &amp; Development</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E224377C-D10E-4461-B620-A5EEAB4B31BA"><gtr:id>E224377C-D10E-4461-B620-A5EEAB4B31BA</gtr:id><gtr:name>University of Hokkaido</gtr:name><gtr:address><gtr:line1>Kita 8</gtr:line1><gtr:line2>Nishi 5</gtr:line2><gtr:line3>Kita-ku</gtr:line3><gtr:line4>Sapporo</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Neuroscience Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7F63F731-9323-45F0-AEC5-00FEDAE4B1CB"><gtr:id>7F63F731-9323-45F0-AEC5-00FEDAE4B1CB</gtr:id><gtr:name>Children's National Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7E833A22-66FB-41DB-BB4E-283D08AF9A6E"><gtr:id>7E833A22-66FB-41DB-BB4E-283D08AF9A6E</gtr:id><gtr:name>Janssen Research &amp; Development</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E224377C-D10E-4461-B620-A5EEAB4B31BA"><gtr:id>E224377C-D10E-4461-B620-A5EEAB4B31BA</gtr:id><gtr:name>University of Hokkaido</gtr:name><gtr:address><gtr:line1>Kita 8</gtr:line1><gtr:line2>Nishi 5</gtr:line2><gtr:line3>Kita-ku</gtr:line3><gtr:line4>Sapporo</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F4223E4F-3353-4B25-B21D-211488BDE414"><gtr:id>F4223E4F-3353-4B25-B21D-211488BDE414</gtr:id><gtr:firstName>Stuart G</gtr:firstName><gtr:surname>Cull-Candy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E65D61D8-0915-4516-B367-B81997BC0C68"><gtr:id>E65D61D8-0915-4516-B367-B81997BC0C68</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Farrant</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FJ002976%2F1"><gtr:id>F8990116-1792-46E7-9D2B-9ED6BBF3F301</gtr:id><gtr:title>Neuronal and glial AMPARs: auxiliary subunits as targets for ion channel regulation</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J002976/1</gtr:grantReference><gtr:abstractText>The functions of our brain rely on the chemical communication that takes place between its myriad cells. One of the most important of these chemicals is glutamate, a neurotransmitter responsible for a majority of fast excitatory signaling. Glutamate acts by binding to receptor proteins at points of contact between nerve cells, and most key features of this excitatory signaling are shaped by the basic properties of one specific class of glutamate receptor - the AMPA receptors (AMPARs). AMPARs are ubiquitous; their activity is integral to all fundamental brain functions, including the processes of sensation, thought, emotion and memory. Because of this, dysfunction of AMPARs causes serious neurological disorders. In particular, one subclass of AMPARs that allow the entry of calcium ions into cells is implicated in the aetiology of several conditions, including multiple sclerosis, motor neuron disease, epilepsy, brain damage following stroke or during birth, and brain tumor growth. As AMPARs play a key role in normal cognition, they are also targets for drug treatments aimed at enhancing cognitive function, notably in neurodegenerative conditions such as Parkinson's and Alzheimer's disease.

Understanding AMPARs is essential if we are to dissect their role in disease pathogenesis. Specifically, there is an urgent need to determine the principles that govern AMPAR function at a cellular and molecular level. Recently, our understanding of these processes advanced significantly, with the identification of proteins that directly associate with AMPARs and dictate their properties and behaviour. Two families of proteins have received particular attention - the transmembrane AMPAR regulatory proteins (TARPs) and the cornichons (CNIHs). Our research is aimed at understanding how these 'auxiliary subunits' control the function of AMPA receptors, with the goal of identifying potential avenues for therapeutic intervention. We will use a combination of proven electrophysiology, imaging and molecular approaches to address three specific goals: (1) to reveal how different auxiliary proteins affect the way in which endogenous molecules and exogenous drugs block or potentiate different classes of AMPARs; (2) to identify the specific auxiliary molecules important for the regulation of calcium-permeable AMPARs, and (3) to elucidate the role played by auxiliary proteins in AMPAR changes thought to underlie pathological conditions involving nerve cells and glia (inflammatory pain and white matter damage). 

Potential applications and benefits of this research stem from the fact that it will provide fundamental information about the regulation of an important class of glutamate receptors in nerve cells and glia. It will consolidate our understanding of normal brain function and highlight strategies for treatment of debilitating conditions. By establishing how different auxiliary proteins affect the pharmacology of specific AMPAR subtypes it has the potential to inform new efforts in drug discovery.</gtr:abstractText><gtr:technicalSummary>We will examine how pharmacological, biophysical and molecular properties of neuronal and glial AMPARs are regulated by TARP and cornichon (CNIH) proteins. The identity and role of these auxiliary subunits will be dissected by comparing recombinant and native AMPARs, by examining mutant and transgenic mice, and by targeted molecular intervention to manipulate protein expression or structure. We will use: (1) recombinant AMPARs expressed with specific TARPs and/or CNIHs in tsA201 cells; (2) identified neurons and glia in dissociated cultures, prepared from wild-type (WT) and mutant or transgenic mice; (3) neurons and glia in acute brain slices.

We will use patch-clamp methods to record pharmacologically isolated AMPAR-mediated macroscopic and single-channel currents, and synaptic currents. We will determine defining kinetic properties, voltage-dependence, calcium-permeability and conductance of recombinant, synaptic and extrasynaptic receptors, as well as the efficacy of blockers and allosteric potentiators. We will use a variety of molecular approaches, and antibody-linked quantum dot single particle tracking to explore the influence of specific auxiliary subunits on AMPAR targeting/trafficking. In collaboration with the groups of Dickenson (UCL) and Diamond (NIH) we will examine the contribution of auxiliary subunits to the properties and regulation of calcium-permeable AMPARs in retinal amacrine cells, and in the processing of nociceptive signals in dorsal horn of the spinal cord. Roger Nicoll (UCSF) will collaborate in provision of TARP knockout mice, and related experiments. Experiments using lentiviral constructs will be carried out in collaboration with Stephanie Schorge (UCL). Our research will provide fundamental information about the regulation of AMPARs in neurons and glia. It will contribute to our understanding of normal brain function, highlight potential strategies for treatment of debilitating conditions and inform new efforts in drug discovery.</gtr:technicalSummary><gtr:potentialImpactText>Academic impact: this work has the potential to provide new knowledge and scientific advancement. The beneficiaries of this research will be medical researchers (including those in university departments worldwide) and members of the pharmaceutical industry. By providing a clearer understanding of the impact of auxiliary proteins on the mechanisms of block of calcium-permeable AMPARs and identifying auxiliary AMPAR subunits involved in the regulation and targeting of CP-AMPARs, our work may held identify specific research avenues that will lead to strategies to limit calcium entry and cell damage in diseases where this is a central issue. Similarly, understanding the influence of auxiliary proteins on the efficacy and selectivity of AMPAR potentiators may aid the identification of strategies or drugs to enhance cognition in disease states. In addition, academic benefit may come from our development of any new methodologies and techniques to achieve our goals. In the broader sense, our work will also be of benefit to neuroscience researchers wishing to understand normal brain function. Immediate benefits (through exchange of scientific knowledge) are likely to accrue in the short to medium term, and certainly within the lifetime of the project. The programme of research will also have capacity-building impact through the training of highly skilled researchers, who will acquire specific competencies and broader transferable skills.

Economic and societal impact: Given an ageing population, neurological conditions will assume an ever-growing economic and social burden. In the long term, by informing drug development or otherwise helping to facilitate rational approaches to therapy, our studies may ultimately lead to enhanced health and well-being.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1686387</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>New Target Enablement Group</gtr:department><gtr:description>Daniel Ursu - Eli Lilly UK</gtr:description><gtr:id>CC62D39F-C7E6-4C85-B993-7982B2B22ADD</gtr:id><gtr:impact>None published yet</gtr:impact><gtr:partnerContribution>Join PhD Student (BBSRC) and Lilly provide compounts - AMPA receptor potentiators for us to investigate.</gtr:partnerContribution><gtr:piContribution>Functional experiments with a Joint PhD Student (partially funded by BBSRC) - a CASE award</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's National Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Center for Neuroscience Research</gtr:department><gtr:description>Prof. Vittorio Gallo, Children's National Medical Center, Washington</gtr:description><gtr:id>F2386D50-8047-43B7-99C4-D88D98A5CBBE</gtr:id><gtr:impact>Paper submitted for publication - currently in review process</gtr:impact><gtr:partnerContribution>Allowed access to equipment, and taught us techniques. And carried out collaborative experiments using material not available in UK</gtr:partnerContribution><gtr:piContribution>Visits by SGCC and longer research visit by Dr Maz Zonouzi. We carried out functional studies at UCL, and used equipment in Washington not available in UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>John Isaac - collaboration</gtr:description><gtr:id>50F7C93F-0E3F-4FDD-AA60-0BE4F440EFD2</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:partnerContribution>Intellectual and experimental contribution during weekly lab visits</gtr:partnerContribution><gtr:piContribution>Calcium permeable AMPA receptors and auxiliary subunits: functional studies</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Ingo Greger - collaboration</gtr:description><gtr:id>8801FE09-EB3D-45C7-A00A-FD952437077D</gtr:id><gtr:impact>Paper in press: Mapping the interaction sites between AMPA receptors and TARPs reveals a role for
the receptor N-terminal domain in channel gating (in press) Cell Reports.</gtr:impact><gtr:partnerContribution>Structural studies at the LMB in Cambridge</gtr:partnerContribution><gtr:piContribution>Mapping the interaction sites between AMPA receptors and TARPs which has revealed a role for the receptor N-terminal domain in channel gating</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Janssen Research &amp; Development</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Michael Maher, Janssen R&amp;amp;D, Johnson &amp;amp; Johnson, San Diego, CA</gtr:description><gtr:id>273DC728-3B58-4F9F-84D9-63844FAE40FF</gtr:id><gtr:impact>none</gtr:impact><gtr:partnerContribution>Provided novel molecules that have selective effects on particular subtypes of AMPA receptors in a part of the brain that plays a role in memory formation, and in epilepsy.</gtr:partnerContribution><gtr:piContribution>Functional patch clamp experiments</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hokkaido University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Masahiko Watanabe (NMDAR and stargazin related proteins)</gtr:description><gtr:id>95AA6201-02BE-462B-B17A-2E96508E6B64</gtr:id><gtr:impact>Ali, R., Renzi, M., Fukaya, M., Watanabe, M., Farrant, M. &amp;amp; Cull-Candy, S.G. (2008) Failure of NMDA receptor activation during quantal release at cerebellar mossy fibre-granule cell synapses in adult mice Physiological Society Proceedings PC80, 116P.</gtr:impact><gtr:partnerContribution>Immunogold labelling or receptors and EM. Help with provision of highly specific antibodies for labelling. These antibodies are not commercially available - and are sent to us at no cost (other than transportation).</gtr:partnerContribution><gtr:piContribution>Functional studies of the role of specific receptor subtypes and auxiliary proteins in synaptic transmission.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Institute of Child Health</gtr:department><gtr:description>Hannah Mitchison: Identification of the locus of the neurological defect in the cerebellum of a model of human juvenile Batten disease</gtr:description><gtr:id>9C0451EA-797F-47AA-A43B-4E3664E627A7</gtr:id><gtr:impact>Currently still working on this. A paper is in the pipeline.</gtr:impact><gtr:partnerContribution>Provided us with a transgenic mouse model of human Batten disease - the most common progressive neurodegenerative disorder
of childhood. Provided expert advice and discussion.</gtr:partnerContribution><gtr:piContribution>Functional (patch clamp) and structural experiments on the cerebellum</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>5th European Synapse meeting (Bristol 2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D3A48643-D193-42C6-A83D-23280CA99A90</gtr:id><gtr:impact>Furthering scientific understanding and research internationally.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research Excellence Framework 2014 (HEFCE)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>20268BC7-CE40-4855-908F-FF25FE642E88</gtr:id><gtr:impact>REF panel meeting lasted over several days, multiple times a year to assess UK Biology research as part of the HEFCE Research Excellence Framework which scores all UK UoA's in 2014.

HEFCE decides future funding for UK research based on scores attained.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.ref.ac.uk/</gtr:url><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gordon Conference 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>02BDE743-A5B3-4336-B7C3-DC16F7B5E9DF</gtr:id><gtr:impact>Gordon Conference Invited speaker. Cerebellum. NH, USA (Aug 11-16, 2013) (Chair: Indira Raman &amp;amp; Michael Mauk)

Highly regarded international venue. Valuable discussions with many other workers in the field.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How to publish</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>927AAB36-6BF1-4E0D-B2A3-BA4D97D42B44</gtr:id><gtr:impact>Q &amp;amp; A session
Audience about 100-150

Numerous informal follow ups.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>157000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CASE award (PhD Student Sarah Pearce)</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Not known (please note amount stated above is approx)</gtr:fundingRef><gtr:id>4328550B-D373-49C4-8A72-5FB772003CD8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4C5E084-AC0A-4802-BC9B-FACCC55A267B"><gtr:id>C4C5E084-AC0A-4802-BC9B-FACCC55A267B</gtr:id><gtr:title>Mapping the interaction sites between AMPA receptors and TARPs reveals a role for the receptor N-terminal domain in channel gating.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/895ca50b1ad9ded59e7c85c7727ecaf2"><gtr:id>895ca50b1ad9ded59e7c85c7727ecaf2</gtr:id><gtr:otherNames>Cais O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A72C19B-154B-4C5E-9880-D9C74564B252"><gtr:id>0A72C19B-154B-4C5E-9880-D9C74564B252</gtr:id><gtr:title>Channel properties reveal differential expression of TARPed and TARPless AMPARs in stargazer neurons.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/881239872c07d40529d36cc73d475e35"><gtr:id>881239872c07d40529d36cc73d475e35</gtr:id><gtr:otherNames>Bats C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D80F99AE-4B95-4253-81B4-319BF6CBD84E"><gtr:id>D80F99AE-4B95-4253-81B4-319BF6CBD84E</gtr:id><gtr:title>TARP ?-7 selectively enhances synaptic expression of calcium-permeable AMPARs.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/490e67aa2048d9e21752ebbf6b3297c2"><gtr:id>490e67aa2048d9e21752ebbf6b3297c2</gtr:id><gtr:otherNames>Studniarczyk D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23537453-BAC3-4B07-B8D6-27D81F4B2A2E"><gtr:id>23537453-BAC3-4B07-B8D6-27D81F4B2A2E</gtr:id><gtr:title>Molecular mechanisms contributing to TARP regulation of channel conductance and polyamine block of calcium-permeable AMPA receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9e260cd0fbf7466d778a6c4193b7858a"><gtr:id>9e260cd0fbf7466d778a6c4193b7858a</gtr:id><gtr:otherNames>Soto D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/751D0001-54DC-42BA-B2FB-A2BE726D8463"><gtr:id>751D0001-54DC-42BA-B2FB-A2BE726D8463</gtr:id><gtr:title>A role of TARPs in the expression and plasticity of calcium-permeable AMPARs: evidence from cerebellar neurons and glia.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/881239872c07d40529d36cc73d475e35"><gtr:id>881239872c07d40529d36cc73d475e35</gtr:id><gtr:otherNames>Bats C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/00057309-01DE-48CA-809D-96A0BDA302DA"><gtr:id>00057309-01DE-48CA-809D-96A0BDA302DA</gtr:id><gtr:title>Transmembrane AMPAR regulatory protein ?-2 is required for the modulation of GABA release by presynaptic AMPARs.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b95f192f045e506ee0b2b99c77b62cc"><gtr:id>8b95f192f045e506ee0b2b99c77b62cc</gtr:id><gtr:otherNames>Rigby M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAF23052-25CA-4003-812F-C240DDB5581E"><gtr:id>CAF23052-25CA-4003-812F-C240DDB5581E</gtr:id><gtr:title>Auxiliary Subunit GSG1L Acts to Suppress Calcium-Permeable AMPA Receptor Function.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a04ba9acca2a866fd5378519b6734b55"><gtr:id>a04ba9acca2a866fd5378519b6734b55</gtr:id><gtr:otherNames>McGee TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A558138-303B-422C-B50F-3899FD20E9C4"><gtr:id>8A558138-303B-422C-B50F-3899FD20E9C4</gtr:id><gtr:title>Acid-sensing ion channel 1a drives AMPA receptor plasticity following ischaemia and acidosis in hippocampal CA1 neurons.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55fd441c5edfae8ec799e87334d0276e"><gtr:id>55fd441c5edfae8ec799e87334d0276e</gtr:id><gtr:otherNames>Quintana P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5856B72C-970C-4D42-B977-3E138955930C"><gtr:id>5856B72C-970C-4D42-B977-3E138955930C</gtr:id><gtr:title>GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/730e64bef4581fd748b92ca1d8093038"><gtr:id>730e64bef4581fd748b92ca1d8093038</gtr:id><gtr:otherNames>Zonouzi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30FB2723-DE78-45E8-A255-9AC933828232"><gtr:id>30FB2723-DE78-45E8-A255-9AC933828232</gtr:id><gtr:title>Synapse-specific expression of calcium-permeable AMPA receptors in neocortical layer 5.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50a657ce09b54678adbafd2ea74728f7"><gtr:id>50a657ce09b54678adbafd2ea74728f7</gtr:id><gtr:otherNames>Lalanne T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ABE41DF6-A6BF-4A4C-BEE4-E76FE18160C1"><gtr:id>ABE41DF6-A6BF-4A4C-BEE4-E76FE18160C1</gtr:id><gtr:title>TARP-associated AMPA receptors display an increased maximum channel conductance and multiple kinetically distinct open states.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8079590a09548f9fbd0e15721c38a3aa"><gtr:id>8079590a09548f9fbd0e15721c38a3aa</gtr:id><gtr:otherNames>Shelley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E5664452-E052-43DD-BA65-CD5DC5011B9A"><gtr:id>E5664452-E052-43DD-BA65-CD5DC5011B9A</gtr:id><gtr:title>Cornichons modify channel properties of recombinant and glial AMPA receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5247f6cba8ed83ee72346ffb9d272e9"><gtr:id>b5247f6cba8ed83ee72346ffb9d272e9</gtr:id><gtr:otherNames>Coombs ID</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J002976/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>